Medtech industry commits to collaboration on global compliance
This article was originally published in SRA
The 2010 International Medical Device Industry Compliance Conference that is taking place in Berlin this week provided an ideal backdrop for European and US medtech industry associations to adopt a “trans-Atlantic statement” in which they committed to collaborate on the advancement of global compliance in ethical interactions with healthcare professionals1.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.